We are monitoring the impact of COVID-19 & Recession alarm on Europe CAR T cell Therapy Market Get in touch with us for detailed analysis Know More

Know More

Share on

Europe CAR T cell Therapy Market Research Report - By Target Antigen, Products, Application, Country (the United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 9989
Pages: 100

Europe CAR T cell Therapy Market Size (2022 to 2027)

The CAR T cell Therapy Market in Europe is estimated to grow at a remarkable CAGR from 2022 to 2027.

Y-O-Y growth in the number of cancer cases, the rising occurrence rate of various cancer such as leukemia, lymphoma, and multiple myeloma are majorly driving the European CAR T cell therapy market during the forecast period. Growing investments made by the government and other private organizations are surging the T-cell therapy market growth. Increasing healthcare expenditure and increasing disposable income are fuelling market growth over the forecasting framework.

The cost associated with the CAR T cell therapy market is so expensive and is restraining the market growth to some extent over the forecast timeframe. Also, CAR T cell therapy can cause side effects post-therapy may also hamper the market growth during the forecast period. Lack of awareness regarding T-cell therapy, particularly in rural areas for the therapy process for cancer, restricts the market growth. Poor reimbursement policies from the governments may hamper the CAR T cell therapy market growth in this region.

This research report on the European CAR T Cell therapy market has been segmented and sub-segmented into the following categories.

By Target Antigen:

  • CD20
  • EGFRV III
  • CD19
  • HER2
  • MESO
  • CD22
  • BCMA
  • GD2
  • CD30
  • HER1
  • CD33

By Application:

  • Multiple Myeloma
  • Chronic Lymphocytic Leukemia
  • Mantle Cell Lymphoma
  • Follicular Lymphoma
  • Diffuse large B-cell lymphoma
  • Acute Lymphoblastic Leukemia

By Product: 

  • Allogeneic
  • Autologous

By Therapies: 

  • Axicabtagene ciloleucel (Yescarta)
  • Tisagenlecleucel (Kymriah)

By End User: 

  • Cancer Research Centers
  • Hospitals
  • Academic and Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regional Analysis:

CAR T cell therapy in the European region is expected to account for a substantial share in the global market during the forecast period due to factors such as growing awareness related to health disorders and rising support from government organizations.

The UK CAR T cell therapy market is predicted to lead the European market due to growing research and development activities. Government initiatives taken for introducing reimbursement policies in support of the poor people are leveling up the market growth in this region. Moreover, an increasing number of cases in the country, advancements in technology for advanced and reliable treatment for cancer diseases, growing pharmaceutical industries, and a rise in the number of clinical studies drive the CAR T cell market growth of the Europe region.

The CAR T cell therapy market in Germany is expected to have the highest growth in the region. The factors stimulating the growth are development within a short period, rising investments among the research institute fuelling the market growth. Moreover, with a growing number of cancer cases in adults and children, an increasing number of clinical trials also enhance growth. The launch of various CAR T-cell therapies and drugs is expected to drive market growth in the European region.

Countries such as France, Spain, and Italy are likely to have considerable growth in this region during the forecast period.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the European CAR T cell therapy market profiled in this report are Mustang Bio, Inc., Celgene Corporation, Bluebird Bio, Inc., CARsgen Therapeutics, Ltd., Novartis International AG, Legend Biotech, Sorrento Therapeutics Inc., Kite Pharma, Inc., Immune Therapeutics, Bellicum Pharmaceuticals, Inc. and Pfizer, Inc.

  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. OVERVIEW
    1. Executive Summary
    2. Key Inferences
  4. DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. MARKET SEGMENTATION
    1. By Target Antigen
      1. CD20
      2. EGFRV III
      3. CD19
      4. HER2
      5. MESO
      6. CD22
      7. BCMA
      8. GD2
      9. CD30
      10. HER1
      11. CD33
      12. Y-o-Y Growth Analysis, By Target Antigen
      13. Market Attractiveness Analysis, By Target Antigen
      14. Market Share Analysis, By Target Antigen
    2. By Application
      1. Multiple Myeloma
      2. Chronic Lymphocytic Leukemia
      3. Mantle Cell Lymphoma
      4. Follicular Lymphoma
      5. Diffuse large B-cell lymphoma
      6. Acute Lymphoblastic Leukemia
      7. Y-o-Y Growth Analysis, By Application
      8. Market Attractiveness Analysis, By Application
      9. Market Share Analysis, By Application
    3. By Product
      1. Allogeneic
      2. Autologous
      3. Y-o-Y Growth Analysis, By Product
      4. Market Attractiveness Analysis, By Product
      5. Market Share Analysis, By Product
    4. By Therapies
      1. Axicabtagene ciloleucel (Yescarta)
      2. Tisagenlecleucel (Kymriah)
      3. Y-o-Y Growth Analysis By Therapies
      4. Market Attractiveness Analysis, By Therapies
      5. Market Share Analysis, By Therapies
    5. By End-User
      1. Cancer Research Centers
      2. Hospitals
      3. Academic and Research Institutes
      4. Pharmaceutical Companies
      5. Biotechnology Companies
      6. Contract Research Organizations
      7. Y-o-Y Growth Analysis, By End User
      8. Market Attractiveness Analysis, By End User
  6. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. Europe
      1. Introduction
      2. United Kingdom
      3. Germany
      4. Italy
      5. France
      6. Spain
      7. Rest of Europe
  7. STRATEGIC ANALYSIS
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter's Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. The threat of New Entrants
      4. The Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. MARKET LEADERS' ANALYSIS
    1. Mustang Bio, Inc.,
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Celgene Corporation
    3. Bluebird Bio, Inc.
    4. CARsgen Therapeutics, Ltd.
    5. Novartis International AG
    6. Legend Biotech
    7. Sorrento Therapeutics Inc.
    8. Kite Pharma, Inc.
    9. Immune Therapeutics
    10. Bellicum Pharmaceuticals, Inc.
    11. Pfizer, Inc.
  9. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  11. APPENDIX
    1. List of Tables
    2. List of Figures
  1. Europe Global CAR T cell Therapy Market, By Target Antigen, From 2022 - 2027 (USD Million)
  2. Europe CD 20 Market, By Region, From 2022 - 2027 (USD Million)
  3. Europe EGFRV III Market, By Region, From 2022 - 2027 (USD Million)
  4. Europe CD 19 Market, By Region, From 2022 - 2027 (USD Million)
  5. Europe HER 2 Market, By Region, From 2022 - 2027 (USD Million)
  6. Europe MESO Market, By Region, From 2022 - 2027 (USD Million)
  7. Europe CD 22 Market, By Region, From 2022 - 2027 (USD Million)
  8. Europe BCMA Market, By Region, From 2022 - 2027 (USD Million)
  9. Europe GD 2 Market, By Region, From 2022 - 2027 (USD Million)
  10. Europe CD 30 Market, By Region, From 2022 - 2027 (USD Million)
  11. Europe HER 1 Market, By Region, From 2022 - 2027 (USD Million)
  12. Europe Global CAR T cell Therapy Market, By Application, From 2022 - 2027 (USD Million)
  13. Europe Multiple Myeloma Market, By Region, From 2022 - 2027 (USD Million)
  14. Europe Chronic Lymphocytic Leukemia Market, By Region, From 2022 - 2027 (USD Million)
  15. Europe Mantle Cell Lymphoma Market, By Region, From 2022 - 2027 (USD Million)
  16. Europe Follicular Lymphoma Market, By Region, From 2022 - 2027 (USD Million)
  17. Europe Diffuse large B-cell Lymphoma Market, By Region, From 2022 - 2027 (USD Million)
  18. Europe Acute Lymphoblastic Leukemia Market, By Region, From 2022 - 2027 (USD Million)
  19. Europe Global CAR T cell Therapy Market, By Product, From 2022 - 2027 (USD Million)
  20. Europe Allogeneic Market, By Region, From 2022 - 2027 (USD Million)
  21. Europe Autologous Market, By Region, From 2022 - 2027 (USD Million)
  22. Europe Global CAR T cell Therapy Market, By Therapies, From 2022 - 2027 (USD Million)
  23. Europe Axicabtagene Ciloleucel (Yescarta) Market, By Region, From 2022 - 2027 (USD Million)
  24. Europe Tisagenlecleucel (Kymriah) Market, By Region, From 2022 - 2027 (USD Million)
  25. Europe Global CAR T cell Therapy Market, By End-User, From 2022 - 2027 (USD Million)
  26. Europe Cancer Reasearch Centers Market, By Region, From 2022 - 2027 (USD Million)
  27. Europe Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  28. Europe Academic and Research institutes Market, By Region, From 2022 - 2027 (USD Million)
  29. Europe Pharmaceutical Companies Market, By Region, From 2022 - 2027 (USD Million)
  30. Europe Biotechnology Companies  Market, By Region, From 2022 - 2027 (USD Million)
  31. Europe Contract Research Organizations Market, By Region, From 2022 - 2027 (USD Million)
  32. U.K. Global CAR T cell Therapy Market, By Target Antigen, From 2022 - 2027 (USD Million)
  33. U.K. Global CAR T cell Therapy Market, By Application, From 2022 - 2027 (USD Million)
  34. U.K. Global CAR T cell Therapy Market, By Product, From 2022 - 2027 (USD Million)
  35. U.K. Global CAR T cell Therapy Market, By Therapies, From 2022 - 2027 (USD Million)
  36. U.K. Global CAR T cell Therapy Market, By End-User, From 2022 - 2027 (USD Million)
  37. Germany Global CAR T cell Therapy Market, By Target Antigen, From 2022 - 2027 (USD Million)
  38. Germany Global CAR T cell Therapy Market, By Application, From 2022 - 2027 (USD Million)
  39. Germany Global CAR T cell Therapy Market, By Product, From 2022 - 2027 (USD Million)
  40. Germany Global CAR T cell Therapy Market, By Therapies, From 2022 - 2027 (USD Million)
  41. Germany Global CAR T cell Therapy Market, By End-User, From 2022 - 2027 (USD Million)
  42. France Global CAR T cell Therapy Market, By Target Antigen, From 2022 - 2027 (USD Million)
  43. France Global CAR T cell Therapy Market, By Application, From 2022 - 2027 (USD Million)
  44. France Global CAR T cell Therapy Market, By Product, From 2022 - 2027 (USD Million)
  45. France Global CAR T cell Therapy Market, By Therapies, From 2022 - 2027 (USD Million)
  46. France Global CAR T cell Therapy Market, By End-User, From 2022 - 2027 (USD Million)
  47. Italy Global CAR T cell Therapy Market, By Target Antigen, From 2022 - 2027 (USD Million)
  48. Italy Global CAR T cell Therapy Market, By Application, From 2022 - 2027 (USD Million)
  49. Italy Global CAR T cell Therapy Market, By Product, From 2022 - 2027 (USD Million)
  50. Italy Global CAR T cell Therapy Market, By Therapies, From 2022 - 2027 (USD Million)
  51. Italy Global CAR T cell Therapy Market, By End-User, From 2022 - 2027 (USD Million)
  52. Spain Global CAR T cell Therapy Market, By Target Antigen, From 2022 - 2027 (USD Million)
  53. Spain Global CAR T cell Therapy Market, By Application, From 2022 - 2027 (USD Million)
  54. Spain Global CAR T cell Therapy Market, By Product, From 2022 - 2027 (USD Million)
  55. Spain Global CAR T cell Therapy Market, By Therapies, From 2022 - 2027 (USD Million)
  56. Spain Global CAR T cell Therapy Market, By End-User, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample